Macrophage manufacturing and engineering with 5′-Cap1 and N1-methylpseudouridine-modified mRNA
Open Access
- 31 July 2024
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 32 (3) , 101307
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32271348, 31971141)
- Key Science and Technology Research Project in Jiangxi Province Department of Education
- National Aerospace Science Foundation of China (32371539, 32071284)
- Science and Technology Department of Sichuan Province (2024NSFSC0731)
This publication has 40 references indexed in Scilit:
- Macrophages in health and diseaseCell, 2022
- N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein productsCell Reports, 2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- Classic and new mediators for in vitro modelling of human macrophagesJournal of Leukocyte Biology, 2020
- Comprehensive Integration of Single-Cell DataCell, 2019
- Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MSAnalytical and Bioanalytical Chemistry, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Origin and Functions of Tissue MacrophagesImmunity, 2014
- Macrophage Activation and Polarization: Nomenclature and Experimental GuidelinesImmunity, 2014
- Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNAImmunity, 2005